Wissenschaftliche Publikationen

IXIARO®

June 19, 2019 Cramer JP, Dubischar K, Eder S, Burchard GD, Jelinek T, Jilma B, Kollaritsch H, Reisinger E, Westritschnig K.

Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study.

May 1, 2019 Taucher, Kollaritsch, Dubischar

Persistence of the immune response after vaccination with the Japanese encephalitis vaccine, IXIARO® in healthy adults: A five year follow-up study.

September 1, 2018 Kadlecek, Borja-Tabora, Eder-Lingelbach, Gatchalian, Kiermayr, Sablan, Kundi, Taucher, Dubischar

Antibody Persistence up to 3 Years After Primary Immunization With Inactivated Japanese Encephalitis Vaccine IXIARO in Philippine Children and Effect of a Booster Dose

May 1, 2018 Pearce, Learoyd, Langendorf, Logan

Japanese encephalitis: the vectors, ecology and potential for expansion.

March 1, 2018 Jelinek, Cromer, Cramer, Mills, Lessans, Gherardin, Barnett, Hagmann, Askling, Kiermayr, Kadlecek, Eder-Lingelbach, Taucher, Dubischar

Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO®, JESPECT®) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study.

September 1, 2017 Dubischar KL, Kadlecek V, Sablan JB, Borja-Tabora CF, Gatchalian S, Eder-Lingelbach S, Kiermayr S, Spruth M, Westritschnig K.

Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region.

September 1, 2017 Dubischar KL, Kadlecek V, Sablan B Jr, Borja-Tabora CF, Gatchalian S, Eder-Lingelbach S, Mueller Z, Westritschnig K.

Safety of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children: An Open-label, Randomized, Active-controlled, Phase 3 Study.

November 4, 2015 Schlegl R, Weber M, Wruss J, Low D, Queen K, Stilwell S, Lindblad EB, Möhlen M.

Influence of elemental impurities in aluminum hydroxide adjuvant on the stability of inactivated Japanese Encephalitis vaccine, IXIARO®.

November 3, 2011 Schuller E, Klingler A, Dubischar-Kastner K, Dewasthaly S, Müller Z

Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO(®).

March 21, 2011 Eder S, Dubischar-Kastner K, Firbas C, Jelinek T, Jilma B, Kaltenboeck A, Knappik M, Kollaritsch H, Kundi M, Paulke-Korinek M, Schuller E, Klade CS.

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51.